mTOR inhibitors show promising in vitro activity in bladder cancer and head and neck squamous cell carcinoma

  • Authors:
    • Fiona Schedel
    • Ralph Pries
    • Beate Thode
    • Brigitte Wollmann
    • Sandra Wulff
    • Dieter Jocham
    • Barbara Wollenberg
    • Ingo Kausch
  • View Affiliations

  • Published online on: January 14, 2011     https://doi.org/10.3892/or.2011.1146
  • Pages: 763-768
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Bladder cancer and head and neck squamous cell carcinoma (HNSCC) are frequent but lack efficient therapies especially in advanced disease. Almost no studies on mTOR function and inhibition in these tumor entities have been reported. We examined the gene and protein expression levels of mTOR and its activated form (pmTOR) in three human bladder carcinoma cell lines (RT-4, T24, EJ28) and three HNSCC cell lines (PCI-1, PCI-13, BHY). Furthermore, the consequences of mTOR inhibition by mTOR-specific siRNAs and the mTOR inhibitor temsirolimus were analysed in vitro using immunohistochemical Ki-67 staining, mTOR and pmTOR western blot analysis, MTT assay, as well as cell cycle analysis with flow cytometry. Especially pmTOR protein expression levels showed marked differences between cell lines. siRNA transfection was associated with dose-dependent target protein reduction but not proliferation inhibition or apoptosis. On the contrary, temsirolimus significantly reduced cell viability and induced apoptosis and cell cycle arrest. According to these data, bladder cancer and HNSCC are promising tumor entities for mTOR inhibition with temsirolimus.

Related Articles

Journal Cover

March 2011
Volume 25 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Schedel F, Pries R, Thode B, Wollmann B, Wulff S, Jocham D, Wollenberg B and Kausch I: mTOR inhibitors show promising in vitro activity in bladder cancer and head and neck squamous cell carcinoma . Oncol Rep 25: 763-768, 2011.
APA
Schedel, F., Pries, R., Thode, B., Wollmann, B., Wulff, S., Jocham, D. ... Kausch, I. (2011). mTOR inhibitors show promising in vitro activity in bladder cancer and head and neck squamous cell carcinoma . Oncology Reports, 25, 763-768. https://doi.org/10.3892/or.2011.1146
MLA
Schedel, F., Pries, R., Thode, B., Wollmann, B., Wulff, S., Jocham, D., Wollenberg, B., Kausch, I."mTOR inhibitors show promising in vitro activity in bladder cancer and head and neck squamous cell carcinoma ". Oncology Reports 25.3 (2011): 763-768.
Chicago
Schedel, F., Pries, R., Thode, B., Wollmann, B., Wulff, S., Jocham, D., Wollenberg, B., Kausch, I."mTOR inhibitors show promising in vitro activity in bladder cancer and head and neck squamous cell carcinoma ". Oncology Reports 25, no. 3 (2011): 763-768. https://doi.org/10.3892/or.2011.1146